Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 239

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 239
---
 license or other occupancy agreement with respect to any real property or alter, amend, modify any agreement that terminated any Channel lease; |

| • | make (i) any capital expenditures or other expenditures with respect to property, plant or equipment or (ii) other material expenditures in excess of $100,000 in the aggregate (other than any expenditures in the ordinary course of business); |

| • | make any changes in accounting methods, principles or practices, except insofar as may have been required by the SEC or a change in GAAP or, except as so required, change any assumption underlying, or method of calculating, any bad debt, contingency or other reserve; |

| • | subject to certain exceptions, (i) modify or amend in any material respect, or terminate, any material contract or agreement to which Channel or any of its subsidiaries is party, or (ii) knowingly waive, release or assign any material rights or claims (including any write-off or other compromise of any accounts receivable of Channel or any of its subsidiaries); |

| • | subject to certain exceptions, (i) enter into any contract or agreement, including those relating to the rendering of services or the distribution, sale or marketing by third parties of the products, of, or products licensed by, Channel or any of its subsidiaries or (ii) license any material intellectual property rights to or from any third party; |

| • | except as required to comply with the terms of any Channel employee plan as in effect on the date of the Merger Agreement, (i) take any action with respect to, adopt, enter into, terminate or amend any Channel employee plan (or any other employee benefit or compensation plan, program, policy, agreement or arrangement that would have constituted a Channel employee plan had it been in effect on the date of the Merger Agreement) or any collective bargaining agreement, (ii) increase or alter the compensation (including any compensation opportunities) or benefits of, or pay or grant any bonus or bonus opportunity or severance, change in control, retention, transaction or other similar compensation or benefits, to, any director, officer, employee or consultant, (iii) amend or accelerate the payment, right to payment or vesting of any compensation or benefits, including any outstanding equity or equity-based incentive awards, (iv) pay any benefit not provided for as of the date of the Merger Agreement under any Channel employee plan, (v) grant any awards under any Channel employee plan (or under any other employee benefit or compensation plan, program, policy